Rudin CM, Johnson ML, Paz-Ares L, Nishio M, et al. Ifinatamab Deruxtecan in Patients With Extensive-Stage Small-Cell Lung Cancer: Primary Analysis of the Phase 2 IDeate-Lung01 Trial. J Clin Oncol 2025 Oct 14:101200JCO2502142. doi: 10.1200/JCO-25-02142.
PMID: 41086386